Oral Acyclovir After Penetrating Keratoplasty for Herpes Simplex Keratitis

Authors:
  • ECElisabeth J. Cohen
    Elisabeth J. Cohen
  • LNLien H. Nguyen
    Lien H. Nguyen
  • CRChristopher J. Rapuano
    Christopher J. Rapuano
  • PLPeter R. Laibson
    Peter R. Laibson

Abstract
OCULAR HERPES simplex virus (HSV) is a prevalent disease worldwide. It is estimated that 400,000 to 500,000 people are affected in the United States.1,2 Recurrent epithelial disease, stromal keratitis, and iritis can cause scarring and loss of vision that may require penetrating keratoplasty for visual rehabilitation. Approximately 3.6% of all corneal grafts performed at Wills Eye Hospital, Philadelphia, Pa, from January 1, 1989, through December 31, 1995, were for viral keratitis (herpes simplex and herpes zoster).3 After the corneal transplant, there remains the risk for recurrent HSV keratitis contributing to corneal scarring and graft failure. In addition, herpes simplex keratitis may be associated with increased risk for allograft rejection, contributing to a poor outcome.

This publication has 26 references indexed in Scilit: